Hyphens Pharma International Ltd - ESG Rating & Company Profile powered by AI
If you work at Hyphens Pharma International Ltd and you would like to licence your Sustainability rating, please get in touch. This article includes a questions and answers table on Hyphens Pharma International Ltd. Browse to the bottom of this webpage for potential risks for Hyphens Pharma International Ltd based on sector, location and marketcap.
Hyphens Pharma International Ltd in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 0.0; made up of an environmental score of 0.0, social score of 0.0 and governance score of 0.0.
0.0
Low ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| ... | ... | ... | |
| 1967 | Hospira Inc | 0.3 | Low |
| 1967 | PRA Health Sciences Inc | 0.3 | Low |
| 1970 | Hyphens Pharma International Ltd | 0.0 | Low |
| 1970 | CSPC Innovation Pharmaceutical Co Ltd | 0.0 | Low |
| 1970 | CTC Bio Inc | 0.0 | Low |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Hyphens Pharma International Ltd have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Hyphens Pharma International Ltd disclose current and historical energy intensity?
Sign up for free to unlockDoes Hyphens Pharma International Ltd report the average age of the workforce?
Sign up for free to unlockDoes Hyphens Pharma International Ltd reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Hyphens Pharma International Ltd disclose its ethnicity pay gap?
Sign up for free to unlockDoes Hyphens Pharma International Ltd disclose cybersecurity risks?
Sign up for free to unlockDoes Hyphens Pharma International Ltd offer flexible work?
Sign up for free to unlockDoes Hyphens Pharma International Ltd have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Hyphens Pharma International Ltd disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Hyphens Pharma International Ltd conduct supply chain audits?
Sign up for free to unlockDoes Hyphens Pharma International Ltd disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Hyphens Pharma International Ltd conduct 360 degree staff reviews?
Sign up for free to unlockDoes Hyphens Pharma International Ltd disclose the individual responsible for D&I?
Sign up for free to unlockDoes Hyphens Pharma International Ltd disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Hyphens Pharma International Ltd disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Hyphens Pharma International Ltd disclose water use targets?
Sign up for free to unlockDoes Hyphens Pharma International Ltd have careers partnerships with academic institutions?
Sign up for free to unlockDid Hyphens Pharma International Ltd have a product recall in the last two years?
Sign up for free to unlockDoes Hyphens Pharma International Ltd disclose incidents of discrimination?
Sign up for free to unlockDoes Hyphens Pharma International Ltd allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Hyphens Pharma International Ltd issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Hyphens Pharma International Ltd disclose parental leave metrics?
Sign up for free to unlockDoes Hyphens Pharma International Ltd disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Hyphens Pharma International Ltd disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Hyphens Pharma International Ltd disclose the pay ratio of women to men?
Sign up for free to unlockDoes Hyphens Pharma International Ltd support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Hyphens Pharma International Ltd disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Hyphens Pharma International Ltd reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Hyphens Pharma International Ltd involved in embryonic stem cell research?
Sign up for free to unlockDoes Hyphens Pharma International Ltd disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Hyphens Pharma International Ltd disclose its waste policy?
Sign up for free to unlockDoes Hyphens Pharma International Ltd report according to TCFD requirements?
Sign up for free to unlockDoes Hyphens Pharma International Ltd disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Hyphens Pharma International Ltd disclose energy use targets?
Sign up for free to unlockDoes Hyphens Pharma International Ltd disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Hyphens Pharma International Ltd have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Hyphens Pharma International Ltd
These potential risks are based on the size, segment and geographies of the company.
Hyphens Pharma International Limited, together with its subsidiaries, operates as a specialty pharmaceutical and consumer healthcare company primarily in Singapore, Vietnam, the Philippines, Indonesia, and Malaysia. The company's Specialty Pharma Principals segment sells and markets specialty pharmaceutical products, including Stérimar nasal sprays, Bausch+Lomb eye drops, Vivomixx, Fenosup, Lidose, and Piascledine through distributorship or licensing, and supply agreements. This segment offers products in various therapeutic areas or medical specialties, including dermatology, pediatrics and neonatology, allergy, otorhinolaryngology, orthopedic and rheumatology, radiology, cardiology and interventional cardiology, ophthalmology, gastroenterology, child psychiatry, and family medicine. Its Proprietary Brands segment develops, markets, and sells dermatological products and health supplement products. It offers dermocosmetic products under the Ceradan and TDF brands through medical professionals, such as general practitioners, dermatologists, pediatricians, and pharmacists; health supplement products under the Ocean Health brand directly to consumers via retail channels; and scalp care products under the CG 210 brand. The company's Medical Hypermart and Digital segment engages in the wholesale of pharmaceuticals and medical supplies for healthcare professionals and institutions, and retail pharmacies through tele-sales and sales representatives. This segment also operates an online B2B platform. It also markets and distributes its products in Bangladesh, Brunei, Cambodia, China, Hong Kong, Macau, Myanmar, Oman, Sri Lanka, and South Korea. The company was formerly known as Hyphens Pharma International Pte Ltd and changed its name to Hyphens Pharma International Limited in May 2018. It was founded in 1998 and is headquartered in Singapore. Hyphens Pharma International Limited is a subsidiary of Inomed Holding Pte Ltd.